Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 18
Symposium

111 - Making Decisions to Test for Respiratory Viruses

Friday, October 1, 2021
4:15 PM - 5:30 PM EDT

    Moderator(s)

  • Inger Damon, MD, PhD

    Director Division of High Consequence Pathogens and Pathology
    Centers for Disease Control and Prevention
    Atlanta, GA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Speaker(s)

  • Sarah Turbett, MD

    Associate Director, Clinical Microbiology Laboratories Assistant in Medicine, Division of Infectious Diseases
    Massachusetts General Hospital
    Boston, MA, United States

    Centers for Disease Control and Prevention (Individual(s) Involved: Self): Grant/Research Support; Up to Date (Individual(s) Involved: Self): Author, Other Financial or Material Support

  • KT

    Keipp Talbot, MD, MPH FIDSA

    Infectious Diseases Physician
    Medicine
    Vanderbilt University Medical Center
    Nashville, TN, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Marwan Azar, M.D

    Assistant Professor
    Infectious Diseases
    Yale School of Medicine
    New Haven, CT, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Inger Damon, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sarah Turbett, MD: Centers for Disease Control and Prevention (Individual(s) Involved: Self): Grant/Research Support; Up to Date (Individual(s) Involved: Self): Author, Other Financial or Material Support
Keipp Talbot, MD, MPH FIDSA: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Marwan M. Azar, M.D: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE credits

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • discuss respiratory virus testing in the context of infection control
  • discuss new updates in respiratory virus testing modalities
  • explain respiratory disease epidemiology to inform testing and surveillance for respiratory viruses

Presentations:

  • Respiratory Virus Diagnostics: Diagnostic Testing Management in the Era of COVID-19

    Speaker: Sarah Turbett, MD – Massachusetts General Hospital

  • Using seasonality data to inform respiratory virus testing – judicious use of real time PCR testing

    Speaker: Keipp Talbot, MD, MPH FIDSA – Vanderbilt University Medical Center

  • What’s new with (point of care) testing for Respiratory Viruses?

    Speaker: Marwan M. Azar, M.D – Yale School of Medicine